Lowest Price Guaranteed From USD 4,799
The global needles market is expected to experience significant growth in the coming years attributed to several factors including the increasing prevalence of chronic diseases, a growing geriatric population, increase in the diagnostic procedures, a rising number of hospitals in emerging economies and a global demand for vaccines.
Needles serve various purposes, including drug delivery, dental and surgical procedures, and for blood collection for diagnostic purposes. They consist of three sections: long shaft, slope, and center, and are used for different clinical applications such as drug delivery, aesthetic procedures, and surgical procedures at different skin layers. Further, there are different types of needles, including traditional needles for general drug delivery, filling and filtering needles for vaccination, and safety pins for drawing blood and preventing infection. The choice of needle also depends on the application area, such as pen needles for insulin injection by diabetics, blood sampling needles for diagnostics, and suture needles for surgical purposes. Moreover, the market for syringes and needles is growing, with various factors influencing its dynamics, including technological advancements, market fragmentation, and competitive landscape. The needles market is also expected to expand significantly, with integration of features like retractable needles and shielding mechanisms opening up the revenue prospects for market players. These safety needles help to control bio-waste and reduce the needlestick injuries. However, challenges such as the adoption of needle free technology, alternative routes of administration, and product recalls may impede the needles market growth. The market is also expected to face challenges with the abuse of disposable needles. However, despite the presence of challenges, the global needles market will continue to witness market growth over the forecast period.
The number of hospitals and surgical centers are increasing in both developed and emerging countries, mainly driven by the rising population and increasing incidence of chronic diseases. For example, the UK government announced plans to invest USD 4.3 billion for 40 hospitals and future funding for 48 hospitals by 2030, while China announced plans to invest USD 4.6 billion for the construction of hospitals in Wuhan. This has led to a high demand for medical and surgical devices, including hypodermic needles and blood collection devices. The growth of hospitals and surgical centers is expected to support the needles market growth over the forecast period.
The largest market driver though will be the rise in chronic diseases globally. According to the World Health Organization (WHO), more than 16 billion injections are given each year. Additionally, annually more than 7.5 billion needles are used in home care settings by patients with chronic diseases such as rheumatoid arthritis, diabetes, multiple sclerosis and others.
The medical needles market faces several restraints that may hinder its growth. These include initial resistance to adopting safer medical practices, regulatory changes, and production constraints. However, the convenience offered by non invasive routes of administration such as oral and topical, along with launch and adoption of needle free injection devices will offer the most resistance to the needles market growth.
Traditionally, injectables were invasive and painful, leading patients to prefer alternate drug delivery routes such as oral, topical, and nasal. Among these, the oral route is the most preferred due to its ease of use, convenience, cost-effectiveness, safety, and acceptability. The adoption of alternative drug delivery technologies is increasing globally, with developments like Pfizer's Exubera and Medtronic's Veo insulin pump limiting the use of injectable insulin. Inhalable insulin and oral anemia treatments are also reducing the need for needles. Additionally, advancements in drug delivery systems, such as ingestible injectables and controlled-release formulations, are making treatments more convenient and patient-centric.
A number of companies are also working on development and commercialization of needle free drug delivery devices. In addition, blood collection for diagnostic applications has also recently witnessed the launch of needle free blood collection device from Becton Dickinson in November 2023. The PIVO Pro device can draw blood samples for hospital in-patients from their peripheral IV line, eliminating the need for using hypodermic needles,
The key market opportunities for the needles market is being driven by the surge in adoption of self-administration of drugs by patients, which are easy to use. These self-injecting devices are most commonly used for the treatment of emergency conditions such as allergies or chronic diseases such as diabetes. Self-administration of injectable contraceptives is widely adopted among females to avoid the expense and inconvenience of visits to the clinic. Moreover, companies are focusing on developing novel self-administration devices to meet the growing demand for self-administering injectables. Safety syringes and safety needles are also supporting the self administration trend.
The needles market forecast on the basis of distribution by type (conventional and safety). On the basis of product (pen, suture, blood collection, dental, ophthalmic and other products). On the basis of route of administration (Intravenous, intramuscular, subcutaneous, intradermal and Others). On the basis of raw material (stainless steel, plastic and other raw materials). On the basis of end users (hospitals and clinics, diagnostic centers, home and other end users). By geographical regions, the market is analyzed across North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America.
Based on route of administration, the needles market is analyzed across intravenous, intramuscular, subcutaneous, intradermal and others. The intravenous segment is expected to lead the global needles market due to its wide use in various medical settings for applications such as blood sampling, placing intravenous catheters, intravenous drug infusions for medication administration and others. However, the rising cases of chronic diseases, such as diabetes, and the advent of needles that are compatible with high-power injectable technology and can withstand high pressure, is driving stronger growth in the subcutaneous market segment.
Based on region, the needles industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Europe is expected to lead the overall needles market due to the constantly improving healthcare infrastructure in the region, which is responsible for the market growth. Moreover, the growing population is contributing to the market expansion. On the other hand, the Asia Pacific region is likely to witness significant increase in CAGR over the forecast period. This is driven by factors such as the growing target population, increasing healthcare expenditure, and awareness about blood donation.
Key market players that are engaged in needles market are (in alphabetical order) Becton Dickinson, Cook Medical, Ethicon, Johnson & Johnson, Medtronic, NIPRO Medical, Novo Nordisk, Smiths Medical, Stryker and Vita Needle Company. This market report includes an easily searchable excel database of all the needles companies worldwide.
by Route of Administration
by Raw Material
by End Users
Key Geographical Regions
|Key Market Players
Recent Developments in Needles Market
There has been recent activity in the needles industry and some of the key developments have been mentioned below: